Comparative efficacy of a novel Bacillus subtilis-based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigs

Abstract In this study, we assessed the efficacy of a novel Bacillus subtilis probiotic in improving growth performance and gut responses in comparison to pharmacological zinc oxide (ZnO) in nursery pigs. A total of 96 piglets were randomly assigned to four groups: Negative control (NC), Positive co...

Full description

Bibliographic Details
Main Authors: Sudhanshu Sudan, Lauren Fletcher, Xiaoshu Zhan, Serena Dingle, Rob Patterson, Lee-Anne Huber, Robert Friendship, Elijah G. Kiarie, Julang Li
Format: Article
Language:English
Published: Nature Portfolio 2023-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-31913-0
_version_ 1827979509024948224
author Sudhanshu Sudan
Lauren Fletcher
Xiaoshu Zhan
Serena Dingle
Rob Patterson
Lee-Anne Huber
Robert Friendship
Elijah G. Kiarie
Julang Li
author_facet Sudhanshu Sudan
Lauren Fletcher
Xiaoshu Zhan
Serena Dingle
Rob Patterson
Lee-Anne Huber
Robert Friendship
Elijah G. Kiarie
Julang Li
author_sort Sudhanshu Sudan
collection DOAJ
description Abstract In this study, we assessed the efficacy of a novel Bacillus subtilis probiotic in improving growth performance and gut responses in comparison to pharmacological zinc oxide (ZnO) in nursery pigs. A total of 96 piglets were randomly assigned to four groups: Negative control (NC), Positive control (PC, 3000 mg Zn /kg feed), B.subtilis low dose (BS9-L, 2 × 107 CFU/pig) and B.subtilis high dose (BS9-H, 2 × 109 CFU/pig). Growth performance, diarrhea rate, gut mucosal gene expression and fecal microbial populations were evaluated. B.subtilis administration did not improve piglet bodyweight. BS9-L showed (P < 0.05) higher average daily gain (ADG) in Period 2 (D14-D28). BS9 groups had (P < 0.001) lower feed conversion ratio (FCR) in Period 2 (D14-D28) and overall. Like the ZnO-group, BS9 groups had lower (P < 0.01) diarrhea rate. A significant reduction (P < 0.05) in fecal E. coli, total coliforms, and an increase in lactic acid bacteria and Bacillus spp. in BS9 groups was observed. BS9 group had reduced (P < 0.05) mRNA levels of intestinal IL-8 and higher levels of MUC-1 and occludin and TJP-1 compared to negative control. These findings suggest that probiotic BS9, may promote growth performance, and ameliorate various indicators of intestinal health in piglets. Hence, it may serve as a prospective alternative to ZnO growth promoter in commercial swine production.
first_indexed 2024-04-09T21:37:53Z
format Article
id doaj.art-5b46f069ccdd4903b60003858efd335b
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T21:37:53Z
publishDate 2023-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-5b46f069ccdd4903b60003858efd335b2023-03-26T11:09:58ZengNature PortfolioScientific Reports2045-23222023-03-0113111210.1038/s41598-023-31913-0Comparative efficacy of a novel Bacillus subtilis-based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigsSudhanshu Sudan0Lauren Fletcher1Xiaoshu Zhan2Serena Dingle3Rob Patterson4Lee-Anne Huber5Robert Friendship6Elijah G. Kiarie7Julang Li8Department of Animal Biosciences, University of GuelphDepartment of Animal Biosciences, University of GuelphDepartment of Animal Biosciences, University of GuelphDepartment of Animal Biosciences, University of GuelphCBS Bio Platforms IncDepartment of Animal Biosciences, University of GuelphDepartment of Population Medicine, University of GuelphDepartment of Animal Biosciences, University of GuelphDepartment of Animal Biosciences, University of GuelphAbstract In this study, we assessed the efficacy of a novel Bacillus subtilis probiotic in improving growth performance and gut responses in comparison to pharmacological zinc oxide (ZnO) in nursery pigs. A total of 96 piglets were randomly assigned to four groups: Negative control (NC), Positive control (PC, 3000 mg Zn /kg feed), B.subtilis low dose (BS9-L, 2 × 107 CFU/pig) and B.subtilis high dose (BS9-H, 2 × 109 CFU/pig). Growth performance, diarrhea rate, gut mucosal gene expression and fecal microbial populations were evaluated. B.subtilis administration did not improve piglet bodyweight. BS9-L showed (P < 0.05) higher average daily gain (ADG) in Period 2 (D14-D28). BS9 groups had (P < 0.001) lower feed conversion ratio (FCR) in Period 2 (D14-D28) and overall. Like the ZnO-group, BS9 groups had lower (P < 0.01) diarrhea rate. A significant reduction (P < 0.05) in fecal E. coli, total coliforms, and an increase in lactic acid bacteria and Bacillus spp. in BS9 groups was observed. BS9 group had reduced (P < 0.05) mRNA levels of intestinal IL-8 and higher levels of MUC-1 and occludin and TJP-1 compared to negative control. These findings suggest that probiotic BS9, may promote growth performance, and ameliorate various indicators of intestinal health in piglets. Hence, it may serve as a prospective alternative to ZnO growth promoter in commercial swine production.https://doi.org/10.1038/s41598-023-31913-0
spellingShingle Sudhanshu Sudan
Lauren Fletcher
Xiaoshu Zhan
Serena Dingle
Rob Patterson
Lee-Anne Huber
Robert Friendship
Elijah G. Kiarie
Julang Li
Comparative efficacy of a novel Bacillus subtilis-based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigs
Scientific Reports
title Comparative efficacy of a novel Bacillus subtilis-based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigs
title_full Comparative efficacy of a novel Bacillus subtilis-based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigs
title_fullStr Comparative efficacy of a novel Bacillus subtilis-based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigs
title_full_unstemmed Comparative efficacy of a novel Bacillus subtilis-based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigs
title_short Comparative efficacy of a novel Bacillus subtilis-based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigs
title_sort comparative efficacy of a novel bacillus subtilis based probiotic and pharmacological zinc oxide on growth performance and gut responses in nursery pigs
url https://doi.org/10.1038/s41598-023-31913-0
work_keys_str_mv AT sudhanshusudan comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs
AT laurenfletcher comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs
AT xiaoshuzhan comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs
AT serenadingle comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs
AT robpatterson comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs
AT leeannehuber comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs
AT robertfriendship comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs
AT elijahgkiarie comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs
AT julangli comparativeefficacyofanovelbacillussubtilisbasedprobioticandpharmacologicalzincoxideongrowthperformanceandgutresponsesinnurserypigs